154
Views
12
CrossRef citations to date
0
Altmetric
Case Report

Terlipressin-induced hyponatremic seizure

, , , , , , , , & show all
Pages 501-504 | Received 02 Nov 2009, Accepted 10 Nov 2009, Published online: 22 Mar 2010

References

  • D'Amico G, De Franchis R. Upper digestive bleeding in cirrhosis. Post-therapeutic outcome and prognostic indicators. Hepatology 2003;38:599–612.
  • Chalasani N, Kahi C, Francois F, Pinto A, Marathe A, Bini EJ, Improved patient survival after acute variceal bleeding: a multicenter, cohort study. Am J Gastroenterol 2003;98:653–9.
  • Bosch J, Abraldes JG, Berzigotti A, Garcia-Pagan JC. Portal hypertension and gastrointestinal bleeding. Semin Liver DisSemin Liver Dis 2008;28:3–25.
  • Seo YS, Kim YH, Ahn SH, Yu SK, Baik SK, Choi SK, Clinical features and treatment outcomes of upper gastrointestinal bleeding in patients with cirrhosis. J Korean Med SciMed Sci 2008;23:635–43.
  • de Franchis R. Evolving consensus in portal hypertension. Report of the Baveno IV consensus workshop on methodology of diagnosis and therapy in portal hypertension. J Hepatol 2005;43:167–76.
  • Garcia-Tsao G, Sanyal AJ, Grace ND, Carey W. Prevention and management of gastroesophageal varices and variceal hemorrhage in cirrhosis. Hepatology (Baltimore, Md) 2007;46:922–38.
  • Foucher J, Chanteloup E, Vergniol J, Castera L, Le Bail B, Adhoute X, Diagnosis of cirrhosis by transient elastography (FibroScan): a prospective study. Gut 2006;55:403–8.
  • Yoneda M, Mawatari H, Fujita K, Endo H, Iida H, Nozaki Y, Noninvasive assessment of liver fibrosis by measurement of stiffness in patients with nonalcoholic fatty liver disease (NAFLD). Dig Liver Dis 2008;40:371–8.
  • Holmes CL, Landry DW, Granton JT. Science review: Vasopressin and the cardiovascular system part 1–receptor physiology. Crit Care 2003;7:427–34.
  • Bosch J, Lebrec D, Jenkins SA. Development of analogues: successes and failures. Scand J Gastroenterol Suppl 1998;226:3–13.
  • Dunwoodie E, Jowett S. Terlipressin causing a hyponatraemic seizure. Scand J Gastroenterol 2007;42:665.
  • Douriez E, Mollard P, Laval C, Albengres E, Laporte JP, Tillement JP. Severe hyponatremia after repeated administration of terlipressin (in French). Therapie 1993;48:518–9.
  • Martin-Llahi M, Pepin MN, Guevara M, Diaz F, Torre A, Monescillo A, Terlipressin and albumin vs albumin in patients with cirrhosis and hepatorenal syndrome: a randomized study. Gastroenterology 2008;134:1352–9.
  • Sanyal AJ, Boyer T, Garcia-Tsao G, Regenstein F, Rossaro L, Appenrodt B, A randomized, prospective, double-blind, placebo-controlled trial of terlipressin for type 1 hepatorenal syndrome. Gastroenterology 2008;134:1360–8.
  • Salerno F, Gerbes A, Gines P, Wong F, Arroyo V. Diagnosis, prevention and treatment of hepatorenal syndrome in cirrhosis. Gut 2007;56:1310–18.
  • Arroyo V, Fernandez J, Gines P. Pathogenesis and treatment of hepatorenal syndrome. Semin Liver Dis 2008;28:81–95.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.